Analyst Ratings for Blueprint Medicines (BPMC) [Neutrals]
BPMC Rating Summary
BPMC Price Target Summary
- Highest: $125.00 (H.C. Wainwright)
- Lowest: $43.00 (Leerink Partners)
- Average: $85.71
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$85.71 (-1.1%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 80%
Avg. $ Target:
$85.71 (-1.1%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 80%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/19/2021 | Morgan Stanley » Updated 10/27/2023 |
Michael Ulz | New Coverage | Equalweight (N/A) |
63.00 (59.00) |
111.99 (86.65) |
-22.63% | Details |
| 3/31/2021 | Credit Suisse | Brad Canino | New Coverage | Neutral (N/A) |
100.00 (N/A) |
92.01 (86.65) |
-5.83% | Details |
 |
||||||||
|
||||||||
